Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

591 ARTÍCULOS , VIENDO DEL 151 AL 165

Effectiveness of acupuncture combined with donepezil for Alzheimer's disease: A systematic review and meta-analysis

Wu Y, Zhan Y, Zhu W, Pei J.

Medicine (Baltimore). 2025 Jun 6;104(23):e42651. doi: 10.1097/MD.0000000000042651.

Implication for Clinical Trials From Longitudinal Tau-PET Accumulation Across Biological Alzheimer Disease Stages

Trudel L, Therriault J, Macedo AC, Servaes S, Hosseini SA, Bezgin G, Aumont E, Rahmouni N, Fernandez Arias J, Zheng Y, Wang YT, Chan T, Hall BJ, Hopewell R, Hsiao CH, Ferreira PCL, Bellaver B, Vitali P, Soucy JP, Pascoal TA, Gauthier S, Rosa-Neto P; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2025 Oct 21;105(8):e214111. doi: 10.1212/WNL.0000000000214111. Epub 2025 Sep 23.

The psychological impact of the disclosure of the diagnosis of Alzheimer's disease on informal caregivers

Singh Solorzano C, Bonomini C, Rosini S, Passeggia I, Zanetti O, Pievani M, Frisoni GB, Festari C.

Alzheimers Dement. 2025 Sep;21(9):e70412. doi: 10.1002/alz.70412.

Hypothalamic imaging in Alzheimer's disease and Lewy body dementia: A systematic review and meta-analysis

Laurell AA, Shah SN, Rahmati M, O'Brien JT, Underwood BR.

Neurobiol Aging. 2025 Nov;155:87-99. doi: 10.1016/j.neurobiolaging.2025.07.011. Epub 2025 Jul 18.

Effects of cerebellar intermittent theta-burst stimulation on patients with Alzheimer's disease: A randomized controlled trial

Zhang X, Sun Z, Wu D, Shi X, Song C, Guan X, Hao J, Guo Y, Wang X, Wei D, Liu Z, Zhao J, Jiang W.

J Alzheimers Dis. 2025 Oct;107(3):1187-1199. doi: 10.1177/13872877251366656. Epub 2025 Aug 13.

Neuropsychological differential diagnosis of Alzheimer's disease and Lewy body dementia: A systematic review

Julio-Ramos T, Mora-Castelleto V, Foncea-González C, Adames-Valencia C, Cigarroa I, Méndez-Orellana C, Toloza-Ramirez D.

Neurologia (Engl Ed). 2025 Nov-Dec;40(9):884-914. doi: 10.1016/j.nrleng.2025.10.001. Epub 2025 Oct 6.

ABBV-552 in patients with mild Alzheimer's disease: a randomized phase IIb trial

Lynch SY, Jia J, Miles N, Boiser J, Buhl DL, Graff O, Zadikoff C.

Alzheimers Dement. 2025 Dec;21(12):e70994. doi: 10.1002/alz.70994.

Evaluation of cognitive, functional, and behavioral effects observed in EMERGE, a phase 3 trial of aducanumab in people with early Alzheimer's disease

Cummings J, Cohen S, Murphy J, Brothers HM, Nejati M, Forrestal F, de Moor C, O'Gorman J, Harrison J, Jaeger J, Mummery CJ, Porsteinsson AP, Potashman M, Tian Y, Yang L, He P, Haeberlein SB.

Alzheimers Dement. 2025 Jun;21(6):e70224. doi: 10.1002/alz.70224.

Digital Detection of Dementia in Primary Care: A Randomized Clinical Trial

Boustani MA, Ben Miled Z, Owora AH, Fowler NR, Dexter P, Puster E, Grout RW, Summanwar D, Erazo SF, Disla S, Coppedge K, Galvin JE.

JAMA Netw Open. 2025 Nov 3;8(11):e2542222. doi: 10.1001/jamanetworkopen.2025.42222.

The future of Alzheimer's disease risk prediction: a systematic review

Nazir S.

Neurol Sci. 2025 Aug;46(8):3377-3390. doi: 10.1007/s10072-025-08167-x. Epub 2025 Apr 12.

Neuropathological changes and amyloid-related imaging abnormalities in Alzheimer's disease treated with aducanumab versus untreated: a retrospective case-control study

Boon BDC, Piura YD, Moloney CM, Chalk JL, Lincoln SJ, Rutledge MH, Rothberg DM, Kouri N, Hinkle KM, Roemer SF, Johnson DR, Burkett BJ, Lowe VJ, Petersen RC, Dickson DW, Reichard RR, Nguyen AT, Graff-Radford J, Knopman DS, Graff-Radford NR, Murray ME.

Lancet Neurol. 2025 Nov;24(11):931-944. doi: 10.1016/S1474-4422(25)00313-8.

Resistance exercise to reduce risk of falls in people with Alzheimer's disease: a randomised clinical trial

Cámara-Calmaestra R, Martínez-Amat A, Aibar-Almazán A, Hita-Contreras F, de Miguel-Hernando N, Rodríguez-Almagro D, Jiménez-García JD, Achalandabaso-Ochoa A.

Physiotherapy. 2025 Mar;126:101440. doi: 10.1016/j.physio.2024.101440. Epub 2024 Oct 28.

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

Bateman RJ, Li Y, McDade EM, Llibre-Guerra JJ, Clifford DB, Atri A, Mills SL, Santacruz AM, Wang G, Supnet C, Benzinger TLS, Gordon BA, Ibanez L, Klein G, Baudler M, Doody RS, Delmar P, Kerchner GA, Bittner T, Wojtowicz J, Bonni A, Fontoura P, Hofmann C, Kulic L, Hassenstab J, Aschenbrenner AJ, Perrin RJ, Cruchaga C, Renton AE, Xiong C, Goate AA, Morris JC, Holtzman DM, Snider BJ, Mummery C, Brooks WS, Wallon D, Berman SB, Roberson E, Masters CL, Galasko DR, Jayadev S, Sanchez-Valle R, Pariente J, Kinsella J, van Dyck CH, Gauthier S, Hsiung GR, Masellis M, Dubois B, Honig LS, Jack CR, Daniels A, Aguillón D, Allegri R, Chhatwal J, Day G, Fox NC, Huey E, Ikeuchi T, Jucker M, Lee JH, Levey AI, Levin J, Lopera F, Roh J, Rosa-Neto P, Schofield PR; Dominantly Inherited Alzheimer's Disease–Trials Unit.

Lancet Neurol. 2025 Apr;24(4):316-330. doi: 10.1016/S1474-4422(25)00024-9.

The effect of modified donanemab titration on amyloid-related imaging abnormalities with edema/effusions and amyloid reduction: 18-month results from TRAILBLAZER-ALZ 6

Wang H, Nery ESM, Ardayfio P, Khanna R, Svaldi DO, Shcherbinin S, Xu W, Andersen SW, Hauck PM, Brooks DA, Collins EC, Salloway S, Mintun MA, Sims JR.

J Prev Alzheimers Dis. 2025 Sep;12(8):100266. doi: 10.1016/j.tjpad.2025.100266. Epub 2025 Jul 5.

Modulation of Cortical and Hippocampal Functional MRI Connectivity Following Transcranial Alternating Current Stimulation in Mild Alzheimer Disease

Wang T, Yan S, Shan Y, Xue H, Xing Y, Bi S, Chen Z, Xi H, Qi Z, Tang Y, Lu J.

Radiology. 2025 Jun;315(3):e241463. doi: 10.1148/radiol.241463.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias